Orange Health Labs Pharmacovigilance Analyst Interview: Rounds, Questions and Preparation

What the job involves

A Pharmacovigilance Analyst collects, assesses, and reports adverse event data for drugs and medical devices to ensure patient safety and regulatory compliance. Day to day, they triage individual case safety reports (ICSRs), perform causality and seriousness assessments, write narratives, and submit reports to health authorities within strict timelines. They also support signal detection, literature screening, and periodic safety reports.

Role and Technical Knowledge

1. 1

   What is the difference between an adverse event (AE) and an adverse drug reaction (ADR)?

   Explain that an AE is any untoward medical occurrence after drug use, which may not be causally related, while an ADR is a harmful and unintended response with a reasonable causal link. Give a simple example to show clarity.

2. 2

   What are the four minimum criteria for a valid ICSR?

   List: identifiable patient, identifiable reporter, suspect product, and adverse event. Mention that missing any one makes the report invalid and that follow-up is needed.

3. 3

   How do you determine the seriousness of an adverse event?

   Cover the regulatory criteria: death, life-threatening, hospitalization or prolongation, disability, congenital anomaly, or medically important event. Emphasize that seriousness is not the same as severity.

4. 4

   What is MedDRA and why is it used in pharmacovigilance?

   Explain that MedDRA is a standardized medical dictionary for regulatory activities, used to code AEs consistently for analysis and reporting. Mention its hierarchy from LLT to SOC.

Practical Scenarios and Case Handling

1. 5

   You receive a call from a patient who reports a rash after taking a new antibiotic. What steps do you take?

   Show a structured approach: collect patient details, reporter information, suspect drug, event description, onset, outcome, and medical history. Then explain documentation, causality assessment, and reporting timelines.

2. 6

   How would you handle a case where the reporter has provided incomplete information?

   Describe the importance of follow-up: attempt to contact the reporter for missing data, document attempts, and if still incomplete, mark the case as invalid but retain it. Mention regulatory expectations for follow-up.

3. 7

   What is the difference between a serious and a non-serious case in terms of reporting timelines?

   State that serious unexpected cases often need expedited reporting (e.g., 15 calendar days for initial report), while non-serious cases are usually included in periodic reports. Mention that timelines may vary by country and authority.

4. 8

   How do you code an adverse event using MedDRA if the reported term is 'heart attack'?

   Explain that you would search MedDRA for the closest term, likely 'Myocardial infarction' under the Cardiac disorders SOC. Highlight the importance of not changing the reporter's words but coding accurately.

Regulatory and Industry Awareness

1. 9

   What is the role of CDSCO in pharmacovigilance in India?

   Describe CDSCO as the national regulatory authority that oversees drug safety, including the PvPI program. Mention that it receives ADR reports and can take regulatory actions.

2. 10

   What is a signal in pharmacovigilance and how is it detected?

   Define a signal as new or changed information about a possible causal association between a drug and an event. Mention methods like spontaneous reporting, literature review, and statistical analysis in databases.

3. 11

   What are the key components of a Periodic Safety Update Report (PSUR)?

   Cover sections like introduction, worldwide marketing status, update on actions taken, changes to reference safety information, estimated exposure, and a summary of cases. Emphasize that PSURs are submitted at defined intervals.

4. 12

   Why is Good Pharmacovigilance Practice (GVP) important?

   Explain that GVP ensures consistent and high-quality safety monitoring, protects patients, and meets regulatory requirements. Mention that it covers all steps from data collection to risk minimization.

Behavioural and HR Questions

1. 13

   Why do you want to work in pharmacovigilance, and why our company?

   Show genuine interest in patient safety and drug safety. Research the company's focus areas, such as diagnostics or clinical research, and link your skills to their work without claiming specific insider knowledge.

2. 14

   Describe a time when you had to pay close attention to detail under a deadline.

   Use a STAR example from academics or internships. Highlight how you maintained accuracy, prioritized tasks, and met the deadline without compromising quality.

3. 15

   How do you handle a situation where you disagree with a senior colleague's assessment of a case?

   Emphasize respectful communication, referring to guidelines, and seeking clarification. Show that you value teamwork and patient safety over personal ego.

4. 16

   Where do you see yourself in three years in this role?

   Express a desire to deepen expertise in case processing, move into quality review or signal detection, and contribute to team goals. Avoid saying you want to leave the field.